Aradigm
PrivateLast Round
Series A
Dec 9, 2025
Est. Valuation
$25M
Total Funding Raised
$25M
Company Overview
Aradigm is a healthcare technology company that provides a benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, InsurTech, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aradigm Comps
Public and private peers based on sector, stage, and business model.
Aradigm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 9, 2025 |
Aradigm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| Frist Cressey Ventures | Series A |
| Morgan Health | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
CEO interviewed at the Asembia ASX26 Summit in Las Vegas.
Aradigm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aradigm's valuation, stock price, and market status.
